Evidence-based treatment of cystic fibrosis

Der Internist
F C RingshausenA-M Dittrich

Abstract

Mucoviscidosis (cystic fibrosis [CF]) is the most common autosomal recessive inherited multisystem disease with fatal outcome. It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which lead to a dysfunctional chloride channel and a defective CFTR protein. As a consequence, retention of insufficiently hydrated mucus affects multiple essential organs, mainly the lungs and airways, pancreas, liver, biliary tract and intestines. This leads to inflammation and infection, fibrosis and progressive tissue destruction. Respiratory failure is the major cause of mortality; however, in the no more than 30 years since the molecular characterization of the basic CFTR defect causing CF, tremendous success has been made with respect to the long-term prognosis of people with CF. This improvement in the prognosis was achieved by the cooperative spirit and networking of the very active and international CF research community and by establishing a multidisciplinary clinical CF team that implements the existing evidence in various aspects of standardized care together with the CF patient. This narrative review article presents the evidence in selected aspects of CF treatment, with special consideration ...Continue Reading

References

Oct 29, 2004·Current Opinion in Pulmonary Medicine·Carlos E Milla
May 6, 2010·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN AZ0004 Azithromycin Study Group
Aug 2, 2011·The Journal of Clinical Investigation·Maurizio RennaR Andres Floto
Nov 4, 2011·The New England Journal of Medicine·Bonnie W RamseyUNKNOWN VX08-770-102 Study Group
Dec 3, 2011·The European Respiratory Journal·Valerie WatersFelix Ratjen
Apr 2, 2013·American Journal of Respiratory and Critical Care Medicine·Peter J MogayzelUNKNOWN Pulmonary Clinical Practice Guidelines Committee
Apr 20, 2013·The European Respiratory Journal·Eitan KeremUNKNOWN ECFS Patient Registry Steering Group
Aug 10, 2013·American Journal of Respiratory and Critical Care Medicine·Alison M BinderD Rebecca Prevots
May 16, 2014·The Cochrane Database of Systematic Reviews·Janet H Ferguson, Anne B Chang
May 27, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Carlo CastellaniJ Stuart Elborn
May 27, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Steven ConwayDaniel Peckham
Aug 6, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·H A W M TiddensUNKNOWN ALPINE study investigators
Nov 2, 2014·The European Respiratory Journal·Aline SchöglerMarco P Alves
Mar 5, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Nathalie CoolenPierre-Régis Burgel
May 20, 2015·The New England Journal of Medicine·Claire E WainwrightUNKNOWN TRANSPORT Study Group
Jun 18, 2015·The Cochrane Database of Systematic Reviews·Maggie McIlwaineKerry Dwan
Jun 28, 2015·The Cochrane Database of Systematic Reviews·Thomas RadtkeSusi Kriemler
May 4, 2016·Lancet·J Stuart Elborn
Jul 28, 2016·The Cochrane Database of Systematic Reviews·Ruth Dentice, Mark Elkins
Mar 30, 2017·The Cochrane Database of Systematic Reviews·Alan R SmythSarah J Nevitt
Apr 26, 2017·The Cochrane Database of Systematic Reviews·Simon C Langton Hewer, Alan R Smyth
Sep 22, 2017·The European Respiratory Journal·Sarah K BrodeTheodore K Marras
Nov 4, 2017·The New England Journal of Medicine·Steven M RoweJane C Davies
Nov 4, 2017·The New England Journal of Medicine·Jennifer L Taylor-CousarJ Stuart Elborn
Nov 4, 2017·American Journal of Respiratory and Critical Care Medicine·Christopher H GossAnne L Stephenson
Feb 10, 2018·The Cochrane Database of Systematic Reviews·Sarah J NevittTiffany Dwyer
Feb 24, 2018·Annals of the American Thoracic Society·Jonathan D CogenMargaret Rosenfeld
Mar 7, 2018·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Carlo CastellaniPavel Drevinek
Aug 10, 2018·The Cochrane Database of Systematic Reviews·Jorrit Jv de VriesJulie M Marchant
Sep 7, 2018·The Cochrane Database of Systematic Reviews·Connie Yang, Mark Montgomery
Sep 28, 2018·The Cochrane Database of Systematic Reviews·Peter Wark, Vanessa M McDonald
Nov 10, 2018·American Journal of Respiratory and Critical Care Medicine·Mirjam StahlMarcus A Mall
Jan 11, 2019·Der Internist·Patience Eschenhagen, Carsten Schwarz
Jan 19, 2019·The European Respiratory Journal·Francesco BlasiPaolo Palange
Jan 25, 2019·The Cochrane Database of Systematic Reviews·Lisa M WilsonKaren A Robinson
Feb 3, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Ranjani SomayajiUNKNOWN Antimicrobial Resistance in Cystic Fibrosis InternationalWorking Group
Apr 19, 2019·The Cochrane Database of Systematic Reviews·Kate H Regan, Jayesh Bhatt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacogenomics
Suzanne C Carter, Edward F McKone
Materia Medica Polona. Polish Journal of Medicine and Pharmacy
A T Midro, L L Kulczycki
The European Respiratory Journal
Marcus A Mall, Dominik Hartl
© 2021 Meta ULC. All rights reserved